Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?

在印度，治疗神经性疼痛的首选药物是低剂量的阿米替林、普瑞巴林和加巴喷丁：是否有必要重新审视剂量建议？